"As Federal Courts Review Cannabis Policy and CMS Expands Cannabinoid Access, MMJ's FDA-and-DEA-Compliant Pharmaceutical Track Record Emerges as a Potential Competitive Advantage" stated Duane Boise, CEO MMJ International Holdings.
2026 Copyright © News-Matic.com. All Rights Reserved
